Solvonis Therapeutics Plc (SVNS)
LSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current SVNS market cap is 4.25M. The company's latest EPS is GBP -0.0014 and P/E is -1.14.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 29k | 330k | 219k | 587k |
| Operating Income | -405k | -671k | -450k | -946k | -2.28M |
| Net Income | -494k | -703k | -538k | -954k | -3.12M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 3.1M | 2.76M | 2.59M | 3.13M | 2.43M |
| Total Liabilities | 152k | 520k | 890k | 2.32M | 408k |
| Total Equity | 2.95M | 2.24M | 1.7M | 812k | 2.03M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -413k | -560k | -192k | -254k | -1.14M |
| Investing | -516k | -20k | -8k | -1,000 | -398k |
| Financing | 1.33M | 328k | 128k | 800k | N/A |
| Market Cap | 4.25M |
| Price to Earnings Ratio | -1.14 |
| Price to Sales Ratio | 5.33 |
| Price to Cash Ratio | 16 |
| Price to Book Ratio | 1.81 |
| Dividend Yield | - |
| Shares Outstanding | 2.3B |
| Average Volume (1 week) | 9.41M |
| Average Volume (1 Month) | 22.66M |
| 52 Week Change | 12.12% |
| 52 Week High | 0.235 |
| 52 Week Low | 0.155 |
| Spread (Intraday) | 0.01 (5.26%) |
| Company Name | Solvonis Therapeutics Plc |
| Address |
eccleston yards london SW1W 9NF |
| Website | https://www.graftpolymer.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
